APOE and Alzheimer disease: We observed that the LXR agonist treatment increased ApoE protein expression mainly in neurons of the GCL of DG particularly in the 3xTg-AD mice; however, there was a small population of ApoE overexpressing cells that were not neurons (Fig 7B, a) and expressed GFAP (Fig 6C, a).